MedPath

Abbott Healthcare Products B.V.

🇳🇱Netherlands
Ownership
-
Employees
-
Market Cap
-
Website

Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension

Phase 2
Completed
Conditions
Hypertension
First Posted Date
2005-09-12
Last Posted Date
2009-01-30
Lead Sponsor
Solvay Pharmaceuticals
Registration Number
NCT00160212
Locations
🇦🇺

Site 705, Bracken Ridge, Australia

🇦🇺

Site 706, Caboolture, Australia

🇦🇺

Site 700, Inala, Australia

and more 127 locations

Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type

Phase 3
Terminated
Conditions
Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type
Interventions
Drug: Placebo
First Posted Date
2005-09-12
Last Posted Date
2015-02-09
Lead Sponsor
Solvay Pharmaceuticals
Target Recruit Count
60
Registration Number
NCT00160147
Locations
🇺🇸

Site 912, Phoenix, Arizona, United States

🇺🇸

Site 902, Carson, California, United States

🇺🇸

Site 903, Long Beach, California, United States

and more 48 locations

Study to Evaluate Cardiac Hemodynamics and Safety of SLV320 in Subjects With Congestive Heart Failure

Phase 2
Completed
Conditions
Congestive Heart Failure
First Posted Date
2005-09-12
Last Posted Date
2009-01-30
Lead Sponsor
Solvay Pharmaceuticals
Registration Number
NCT00160134
Locations
🇩🇪

Site 1, Bad Nauheim, Germany

Study to Investigate if Adding Lactulose to Vitamin D and Calcium Has an Effect on the Preservation of Bone in Postmenopausal Women

Phase 4
Completed
Conditions
Osteopenia
First Posted Date
2005-09-12
Last Posted Date
2009-01-30
Lead Sponsor
Solvay Pharmaceuticals
Target Recruit Count
40
Registration Number
NCT00160264
Locations
🇪🇸

Site 1, Barcelona, Spain

🇪🇸

Site 2, Barcelona, Spain

🇪🇸

Site 3, Barcelona, Spain

Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes

Not Applicable
Completed
Conditions
Hypertension
Type 2 Diabetes
First Posted Date
2005-09-12
Last Posted Date
2009-01-30
Lead Sponsor
Solvay Pharmaceuticals
Target Recruit Count
440
Registration Number
NCT00160160
Locations
🇨🇦

Site 26, Calgary, Canada

🇨🇦

Site 27, Montreal, Canada

🇨🇦

Site 30, Quebec, Canada

and more 60 locations

Efficacy and Safety of Moxonidine in Indian Patients

Phase 3
Completed
Conditions
Hypertension
First Posted Date
2005-09-12
Last Posted Date
2009-01-30
Lead Sponsor
Solvay Pharmaceuticals
Target Recruit Count
100
Registration Number
NCT00160277
Locations
🇮🇳

Site 1, Jubillee Hills Hyderabad, India

🇮🇳

Site 2, Mangalore, India

🇮🇳

Site 3, New Delhi, India

Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes

Phase 2
Completed
Conditions
Hot Flushes, Menopause, Postmenopause
Interventions
First Posted Date
2005-09-12
Last Posted Date
2008-08-15
Lead Sponsor
Solvay Pharmaceuticals
Target Recruit Count
1251
Registration Number
NCT00160342
Locations
🇺🇸

Site 37, Montgomery, Alabama, United States

🇺🇸

Site 69, Montgomery, Alabama, United States

🇺🇸

Site 44, Tucson, Arizona, United States

and more 122 locations

Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension

Phase 2
Completed
Conditions
Hypertension
First Posted Date
2005-09-12
Last Posted Date
2007-11-14
Lead Sponsor
Solvay Pharmaceuticals
Registration Number
NCT00160225
Locations
🇮🇹

Site 1, Ranica, Italy

Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secretory Conversion

Phase 4
Completed
Conditions
Secondary Amenorrhea
Interventions
First Posted Date
2005-09-12
Last Posted Date
2010-07-07
Lead Sponsor
Solvay Pharmaceuticals
Target Recruit Count
240
Registration Number
NCT00160199
Locations
🇺🇸

Site 29, Mobile, Alabama, United States

🇺🇸

Site 41, Montgomery, Alabama, United States

🇺🇸

Site 26, Tucson, Arizona, United States

and more 39 locations

Trial to Evaluate Effect of Lactulose on Hard Stools in Patients With Hemorrhoids or Anal Fissures

Phase 4
Terminated
Conditions
Hemorrhoids
Anal Fissures
Interventions
First Posted Date
2005-09-12
Last Posted Date
2008-05-06
Lead Sponsor
Solvay Pharmaceuticals
Target Recruit Count
97
Registration Number
NCT00160290
Locations
🇪🇸

Site 2, Barcelona, Spain

🇪🇸

Site 6, Granada, Spain

🇪🇸

Site 5, Huesca, Spain

and more 5 locations
© Copyright 2025. All Rights Reserved by MedPath